Free scoping read. A written assessment of your manuscript in two business days, at no cost.

Start one
Contents

Academy · Research Data, Analytics & AI · Fixed vs Random Effects CIs

Confidence Intervals in Fixed-Effect and Random-Effects Models: Differences and Reporting

A random-effects confidence interval incorporates a between-study variance term that a fixed-effect interval assumes to be absent. For this reason, the same set of studies can produce two noticeably different interval widths around nearly the same pooled point estimate.

Pubrica AcademyWritten by a biostatistics analyst Reviewed bya systematic review methodologist Published10 October 2026 Last checked10 October 2026 Reading time8 minutes Sources10 peer-reviewed

A fixed-effect model assumes every study included in a meta-analysis is estimating exactly the same true underlying effect, so any difference between studies' observed results is attributed purely to sampling error within each study. A random-effects model instead assumes the true effect itself varies across studies, drawn from a distribution of related but not identical true effects, and it adds an estimate of that between-study variance, usually denoted tau-squared, into the calculation1. This single modeling choice is the most common reason two otherwise identical meta-analyses, run on the same data, report confidence intervals of noticeably different widths.

Learning objectives

  • The core assumption difference between fixed-effect and random-effects models
  • Where the additional between-study variance term enters a random-effects confidence interval
  • How to determine which model’s interval is more defensible for a given dataset

Common misconceptions

  • “Switching from a fixed-effect to a random-effects model mainly changes the pooled point estimate.” In practice, the point estimates of the two models are often very similar when studies carry comparable weight, but their confidence intervals frequently differ substantially, because the random-effects interval incorporates an additional between-study variance term (tau-squared) that the fixed-effect calculation does not include.

Core assumptions of each model

A fixed-effect model treats all variation between studies’ observed results as sampling error around one single, shared true effect, which means every study is assumed to be estimating the identical underlying quantity, differing only in precision according to its sample size1. A random-effects model relaxes this, assuming instead that the true effects in different studies are themselves a sample from a distribution of related true effects, varying because of real differences in populations, interventions, or settings across studies2. DerSimonian and Laird's original 1986 method for random-effects meta-analysis formalized this by introducing a between-study variance component, tau-squared, estimated from the observed heterogeneity among study results, and incorporating it directly into each study's weight in the pooled calculation2.

Point of divergence between the two intervals

In a fixed-effect model, each study's weight in the pooled estimate is the inverse of its own within-study variance alone, so the overall standard error of the pooled estimate, and the resulting confidence interval, is driven entirely by within-study sampling error1. In a random-effects model, each study’s weight is the inverse of its within-study variance plus the shared between-study variance, tau-squared, which both redistributes weight somewhat more evenly across studies of different sizes and, importantly, adds that extra variance term into the standard error used to construct the confidence interval2. The practical consequence, documented across methodological comparisons, is that whenever meaningful between-study heterogeneity exists, the random-effects confidence interval will be wider than the fixed-effect interval calculated from the same data, sometimes substantially so, because it reflects a source of uncertainty that the fixed-effect calculation does not take into account3.

Selecting the model whose interval is reported

The Cochrane Handbook’s guidance is that the choice between models should follow from a judgment about whether the fixed-effect assumption, one shared true effect, is plausible for the specific studies being pooled, rather than being made retrospectively by selecting whichever interval appears more favorable1. Riley, Higgins, and Deeks additionally recommend that, whenever a random-effects model is used and heterogeneity is substantial, a prediction interval, which estimates the range within which a new study's true effect might fall, should be reported alongside the standard confidence interval, because the confidence interval alone describes the uncertainty around the mean effect and does not, by itself, communicate how much individual study results are expected to vary3. IntHout and colleagues' analysis of published Cochrane reviews found that a large majority omitted this prediction interval even in analyses with substantial heterogeneity, which they argue routinely overstates the apparent precision of the pooled result to readers who only see the narrower confidence interval4.

Quantifying the heterogeneity present

Formal heterogeneity statistics inform, but do not settle, the choice between models. Higgins and Thompson’s I-squared statistic estimates the percentage of total variability across study estimates that is attributable to genuine heterogeneity rather than chance, with values often loosely categorized as low, moderate, or high, though the authors themselves caution against treating any specific numeric cutoff as a rigid decision rule5. Tau-squared, the between-study variance estimated directly within a random-effects model, is a complementary statistic expressed in the same units as the effect measure itself, which makes it more directly interpretable for judging how much individual study results might plausibly differ from one another in absolute terms2. Reporting both I-squared and tau-squared, rather than either alone, gives readers a fuller picture than relying on a single heterogeneity statistic to justify a model choice that was, in most cases, better made on clinical and methodological grounds before the data were analyzed.

Transparent reporting of both models rather than post hoc selection

Because the random-effects interval is often, though not always, wider than the fixed-effect interval from the same data, a transparent meta-analysis should state its primary model choice and justification in the methods section, before results are known, and should not switch models after observing which produces a more favorable interval1. Some journals and reporting guidelines now expect both the fixed-effect and random-effects results to be reported, at least in a sensitivity analysis, specifically so readers can judge for themselves how sensitive the overall conclusion is to this modeling choice1. Where the point estimates and intervals of the two models differ substantially, that divergence is itself informative, often pointing to a small number of influential studies or to genuine clinical heterogeneity that merits its own discussion rather than being resolved by reporting whichever model’s output appears more favorable.

Recent methods addressing limitations of both approaches

DerSimonian and Laird’s original method for estimating tau-squared has a well-documented limitation: with a small number of studies, it can underestimate the true between-study variance, which in turn can make a random-effects confidence interval narrower, and therefore apparently more precise, than the underlying heterogeneity justifies2. Alternative methods for estimating tau-squared and constructing the corresponding interval, including approaches that adjust the degrees of freedom used in the calculation, have been developed specifically to address this small-sample bias, and current Cochrane Handbook guidance discusses when these alternative estimators are preferable to the original DerSimonian-Laird approach1. A review's choice of heterogeneity estimator is a further methodological decision, beyond the basic fixed-versus-random choice, that affects the width of the final reported interval and should ideally be stated and justified alongside the model choice itself.

A worked comparison of the two models

In a hypothetical set of five trials of similar size testing the same intervention, four show a modest benefit and one, conducted in a notably different patient population, shows a modest harm. A fixed-effect model, treating this divergence purely as sampling error around one shared true effect, will produce a pooled estimate dominated by the four similar trials and a comparatively narrow interval, because it makes no allowance in the standard error for the possibility that the fifth trial is estimating a genuinely different true effect1. A random-effects model applied to the same five trials will produce a similar point estimate but a visibly wider interval, reflecting the between-study variance implied by the one discordant trial, and, if a prediction interval is also calculated, that prediction interval will be wider still, signaling that a sixth trial conducted in a population resembling the discordant one could plausibly show a different result3. Neither interval is “wrong”; they answer related but distinct questions, and reporting only one without stating which question it answers leaves readers unable to judge how far a specific future application of the pooled result can be trusted.

A further numerical illustration of the same principle uses tau-squared directly. In one hypothetical set of eight trials, a random-effects calculation produces a tau-squared estimate of 0.02 on the log-risk-ratio scale, indicating modest between-study variance, whereas in a second set of eight trials, testing a different intervention, tau-squared is estimated at 0.15, indicating substantially more between-study variance2. Even if both sets of trials produce an identical pooled point estimate and an identical total sample size, the second meta-analysis's random-effects confidence interval will be visibly wider than the first's, purely because of the larger tau-squared term entering its standard error calculation; a fixed-effect interval calculated from either set, by contrast, would ignore this difference entirely and could misleadingly suggest the two bodies of evidence are equally precise1. This is also why two meta-analyses reported in the same journal issue, built from a similar number of trials and participants, can legitimately report very differently sized confidence intervals without either one having made an error: the difference reflects real, measured between-study variance in how consistently the underlying trials agree with one another, not an inconsistency in how carefully either analysis was conducted3.

Key points

Key points

Fixed-effect models assume one shared true effect and build a confidence interval from within-study variance alone, while random-effects models assume varying true effects and add a between-study variance term that typically widens the interval; the choice of model, the choice of heterogeneity estimator, and any heterogeneity statistics used to justify them should be documented before results are known, not after.

Practical application

Practical application

  1. The model should be selected before the analysis, on the basis of the clinical and methodological similarity of the studies. Authors should judge whether a single shared true effect is a plausible assumption for the studies being pooled, rather than selecting the model after observing which interval is narrower.
  2. Heterogeneity statistics should be reported alongside the selected model. I-squared and, for random-effects models, tau-squared should always be presented, so that readers can judge the contribution of the between-study variance term to the width of the reported interval.
  3. A prediction interval should be added when a random-effects model is used with substantial heterogeneity. A prediction interval communicates the expected range of the result of a new study, which a standard confidence interval around the mean effect does not convey.

Frequently asked questions

Not automatically. A random-effects model is generally more appropriate when meaningful clinical or methodological diversity exists among studies, but it is not a substitute for examining that diversity directly; choosing it reflexively without assessing heterogeneity can obscure rather than clarify what the data show.

IntHout and colleagues' review of published Cochrane meta-analyses found prediction intervals were reported in only a small minority of analyses with substantial heterogeneity, likely reflecting that the practice is less familiar to authors than the standard confidence interval, despite methodological guidance recommending it.

References

  1. Deeks JJ, Higgins JPT, Altman DG (editors). Chapter 10: Analysing data and undertaking meta-analyses. In: Cochrane Handbook for Systematic Reviews of Interventions. Cochrane, 2024. read 10 October 2026. View on Cochrane Training
  2. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials. 1986;7(3):177-188. read 10 October 2026. View on ScienceDirect
  3. Riley RD, Higgins JPT, Deeks JJ. Interpretation of random effects meta-analyses. BMJ. 2011;342:d549. read 10 October 2026. View on The BMJ
  4. IntHout J, Ioannidis JPA, Rovers MM, Goeman JJ. Plea for routinely presenting prediction intervals in meta-analysis. BMJ Open. 2016;6(7):e010247. read 10 October 2026. View on BMJ Open
  5. Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statistics in Medicine. 2002;21(11):1539-1558. read 10 October 2026. View on PubMed
  6. Gardner MJ, Altman DG. Confidence intervals rather than P values: estimation rather than hypothesis testing. BMJ. 1986;292(6522):746-750. read 10 October 2026. View on The BMJ
  7. Greenland S, Senn SJ, Rothman KJ, Carlin JB, Poole C, Goodman SN, Altman DG. Statistical tests, P values, confidence intervals, and power: a guide to misinterpretations. European Journal of Epidemiology. 2016;31(4):337-350. read 10 October 2026. View on European Journal of Epidemiology
  8. Guyatt GH, Oxman AD, Vist G, et al. GRADE guidelines: 4. Rating the quality of evidence - study limitations (risk of bias). Journal of Clinical Epidemiology. 2011;64(4):407-415. read 10 October 2026. View on Journal of Clinical Epidemiology
  9. du Prel JB, Hommel G, Rohrig B, Blettner M. Confidence interval or p-value? Part 4 of a series on evaluation of scientific publications. Deutsches Arzteblatt International. 2009;106(19):335-339. read 10 October 2026. View on Deutsches Arzteblatt International
  10. Wasserstein RL, Lazar NA. The ASA Statement on p-Values: Context, Process, and Purpose. The American Statistician. 2016;70(2):129-133. read 10 October 2026. View on Taylor & Francis Online

Every source above is a peer-reviewed article, a publisher’s record of one, or a standard issued by the body that owns it. Each carries the date it was last read. Where a standard moves, this article is revised rather than left up with a note.

How to cite this article

Pick your referencing style and copy it. Your university or target journal may vary the punctuation — check its guide if it has one.

Pubrica Academy. (2026, October 10). Confidence Intervals in Fixed-Effect and Random-Effects Models: Differences and Reporting. Pubrica. https://pubrica.com/academy/confidence-intervals-in-fixed-effect-and-random-effects-model/

This article is written to be learned from. Cite it if you are referring to what it says; if you are using the evidence behind it, cite the sources listed above instead.

Fixed vs Random Effects Decision Note

This note is intended to document and justify the choice of effects model in a meta-analysis.

[ ] Assessed clinical and methodological similarity across the included studies
[ ] Judged whether a single shared true effect is a plausible assumption
[ ] Chose the effects model before, not after, seeing the resulting interval widths
[ ] Reported I-squared and (if random-effects) tau-squared alongside the pooled interval
[ ] Added a prediction interval if heterogeneity is substantial under a random-effects model
[ ] Documented the rationale for the model choice in the methods section

Pubrica AcademyWritten and maintained by Pubrica’s subject matter experts. Articles are revised when the underlying standards change, and each article states the date on which it was last reviewed.

How Pubrica can help

Pubrica’s meta-analysis support team fits both fixed-effect and random-effects models to a dataset, documents the heterogeneity evidence underlying the model choice, and adds prediction intervals where guidance recommends them.

Find something else

Search the Pubrica Academy

Access is free and requires no account. Enter a topic, or open the full library to filter by category, sub-topic or resource type.

Correspondence between model choice and observed heterogeneity in meta-analysis

A scoping assessment is free and takes two business days. It provides a written assessment of what the work requires and which specialist would undertake it.

Get a free quote

Regulations

Check your project against this rule

  1. 1Your work
  2. 2Your details
  3. 3Send
What do you need?

Material you send is held under signed confidentiality, with access limited to the assigned team and encrypted transfer. It is not used to train anything and is not passed to third-party tools. Ask for the agreement before you send anything you would rather cover first.